Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve D Pratt

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|September 14, 2017
Implementation of a human podocyte injury model of chronic kidney disease for profiling of renoprotective compoundsVivek C Abraham, Loan N Miller, Steve D Pratt, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2017
Fragment-based discovery of a potent NAMPT inhibitorAlla Korepanova, Kenton L Longenecker, Steve D Pratt, et al.
Journal of Medicinal Chemistry|August 4, 2006
Novel antibacterial class: a series of tetracyclic derivativesMira M Hinman, Teresa A Rosenberg, Darlene Balli, et al.
Journal of Biomolecular Screening|November 14, 2006
Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonistsJun Chen, Marc R Lake, Reza S Sabet, et al.
Chembiochem : a European Journal of Chemical Biology|January 10, 2018
Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase A as a Structure SurrogateRussell A Judge, Anil Vasudevan, Victoria E Scott, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Novel inhibitors of bacterial protein synthesis: structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variantsRichard F Clark, Sanyi Wang, Zhenkun Ma, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Novel antibacterial classPeter J Dandliker, Steve D Pratt, Angela M Nilius, et al.
Journal of Medicinal Chemistry|November 3, 2018
Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure-Based Drug DesignAdrian D Hobson, Russell A Judge, Ana L Aguirre, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|September 14, 2017
Implementation of a human podocyte injury model of chronic kidney disease for profiling of renoprotective compoundsVivek C Abraham, Loan N Miller, Steve D Pratt, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2017
Fragment-based discovery of a potent NAMPT inhibitorAlla Korepanova, Kenton L Longenecker, Steve D Pratt, et al.
Journal of Medicinal Chemistry|August 4, 2006
Novel antibacterial class: a series of tetracyclic derivativesMira M Hinman, Teresa A Rosenberg, Darlene Balli, et al.
Journal of Biomolecular Screening|November 14, 2006
Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonistsJun Chen, Marc R Lake, Reza S Sabet, et al.
Chembiochem : a European Journal of Chemical Biology|January 10, 2018
Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase A as a Structure SurrogateRussell A Judge, Anil Vasudevan, Victoria E Scott, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Novel inhibitors of bacterial protein synthesis: structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variantsRichard F Clark, Sanyi Wang, Zhenkun Ma, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Novel antibacterial classPeter J Dandliker, Steve D Pratt, Angela M Nilius, et al.
Journal of Medicinal Chemistry|November 3, 2018
Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure-Based Drug DesignAdrian D Hobson, Russell A Judge, Ana L Aguirre, et al.
Pageof 1